[Glucophot BP-"M" analyzer for blood analysis].

Area of Science:

• Biomedical engineering
• Clinical chemistry
• Medical diagnostics

Context:

• Accurate glucose monitoring is crucial for managing diabetes and other metabolic disorders.
• Point-of-care testing (POCT) devices aim to provide rapid and reliable glucose measurements outside traditional laboratories.
• Evaluating the performance of new diagnostic tools under real-world clinical conditions is essential.

Purpose:

• To assess the clinical performance of the miniature Glucophot BP-"M" analyzer for capillary blood glucose measurements.
• To compare the Glucophot BP-"M" analyzer's results against established reference methods (hexokinase) and a commercial glucometer.
• To determine the reproducibility and correctness of the Glucophot BP-"M" analyzer in diverse patient populations.

Summary:

• The Glucophot BP-"M" analyzer was evaluated against the hexokinase reference method and a One Touch-11 glucometer.
• Glucose concentrations in capillary blood were measured in both healthy individuals and patients with various diseases.
• Results indicated that the Glucophot BP-"M" analyzer demonstrated high analytical reliability and met laboratory standards for "dry" chemical methods.

Impact:

• The Glucophot BP-"M" analyzer shows potential as a reliable tool for rapid, point-of-care glucose testing.
• Its accuracy and reproducibility support its use in diverse clinical environments, potentially improving patient management.
• This validation contributes to the evidence base for miniature diagnostic devices in healthcare settings.